TrialScope Announces New EudraCT Reporting


Applied Clinical Trials

TrialScope announced the latest release of its PharmaCM platform (v.2.2)

TrialScope, a provider of clinical trial transparency and compliance solutions, announced the latest release of its PharmaCM platform (v.2.2) that automates and manages clinical trial results reporting via the European Medicines Agency’s European Clinical Trials Database (EudraCT).

The new EudraCT results reporting functionality is a first-to-market solution that enables clinical trial sponsors to convert results data formatted for US National Institutes of Health registry ( to the format required for EudraCT.  This approach reduces the data entry effort for EudraCT results by up to 85% and applies preconfigured workflows and audit trails to the complex process of disclosing clinical trial results to the European registry. The requirement to report trial summary results became mandatory for sponsors as of July 21, 2014.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.